BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20188697)

  • 1. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
    Kurzawa L; Pellerano M; Morris MC
    Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
    Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of GFP Native Protein for Detection of Its Intracellular Uptake by Cell-Penetrating Peptides.
    Kadkhodayan S; Sadat SM; Irani S; Fotouhi F; Bolhassani A
    Folia Biol (Praha); 2016; 62(3):103-9. PubMed ID: 27516189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
    Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
    Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
    Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
    PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
    Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
    Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.
    Li Y; Zheng X; Cao Z; Xu W; Zhang J; Gong M
    Int J Pharm; 2012 Sep; 434(1-2):209-14. PubMed ID: 22688249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
    Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
    Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Delivery of Antisense Oligonucleotides by an Amphipathic Cell-Penetrating Peptide in Acinetobacter baumannii.
    Chen Z; Nie D; Hu Y; Li M; Hou Z; Mao X; Luo X; Xue X
    Curr Drug Deliv; 2019; 16(8):728-736. PubMed ID: 31244437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.
    Muñoz-Morris MA; Heitz F; Divita G; Morris MC
    Biochem Biophys Res Commun; 2007 Apr; 355(4):877-82. PubMed ID: 17331466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide carrier for the delivery of elastin into fibroblast cells.
    Nasrollahi SA; Fouladdel S; Taghibiglou C; Azizi E; Farboud ES
    Int J Dermatol; 2012 Aug; 51(8):923-9. PubMed ID: 22788807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptide-functionalized quantum dots for intracellular delivery.
    Liu BR; Huang YW; Chiang HJ; Lee HJ
    J Nanosci Nanotechnol; 2010 Dec; 10(12):7897-905. PubMed ID: 21121277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.